BOOSTER EFFECTS WITH AUTOIMMUNE TREATMENTS IN PATIENTS WITH POOR RESPONSE TO INITIAL COVID-19 VACCINE

Brief description of study

The main reason this research study is being done is to see if an additional COVID-19 vaccine (a booster) will help people with autoimmune disease who are taking certain medications that weaken their immune system develop a better response to the vaccine. The study doctors also want to see if temporarily stopping some medications (such as mycophenolate mofetil, mycophenolic acid, and methotrexate) around the time of vaccination will help the immune system respond to the COVID-19 vaccination.


Clinical Study Identifier: s21-01043
ClinicalTrials.gov Identifier: NCT05000216
Principal Investigator: Amit Saxena.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.